Thanks, I did a number of discounted cash flows in the past, but never worked on bringing them back to an individual share price which I'm assuming is DCF / total shares & options. I'm sure I can google and work it out, but personally, I might prefer to pay a firm and avoid questions. Any tips on competitively priced firms?
Thanks Gbuckell, This is now clear. What about if we issue options without revaluing, .i.e. we assumed price would not have changed so don't revalue before issuing the options.
yes, I've come to this second hand and am not across the whole process. I think the question is coming from the fact that it seems costly 9company pays outside provider) to have to value every 60 days. Do you have to value every 60 days regardless? The company is hiring new employees every few months so issuing options every few months and will probably raise funds once every year.
yes, I've come to this second hand and am not across the whole process. I think the question is coming from the fact that it seems costly 9company pays outside provider) to have to value every 60 days. Do you have to value every 60 days regardless? The company is hiring new employees every few months so issuing options every few months and will probably raise funds once every year.
Thanks. I was unclear on my question. If the option valuation on 1 Jan is £10 and circumstances change (e.g. capital is raised) on 1 April, is there a fine if new valuation is requested 1 Aug rather than by 1 June (within 60 days)?
Thanks. I did a bit of reading this morning and it seems like the supplier should include VAT on the invoice even if it is shipped to the USA. So on your point 1, then, I agree assuming supplier puts VAT on invoice.
Hi Les,
The business is a research study on nutrition. The main study takes place in the UK, however there will be a very small study in the US. All components such as medical devices will be shipped from supplier country of origin to the US. Medical sample results will then be shipped from US to supplier country of origin (European). All supplier invoices will be to the UK VAT registered company. The company is at research stage so has no customers or revenue. Thanks, Margaret
My answers
Thanks, I did a number of discounted cash flows in the past, but never worked on bringing them back to an individual share price which I'm assuming is DCF / total shares & options. I'm sure I can google and work it out, but personally, I might prefer to pay a firm and avoid questions. Any tips on competitively priced firms?
Thanks Ruddles. That clarifies the issue for me.
Thanks Gbuckell, This is now clear. What about if we issue options without revaluing, .i.e. we assumed price would not have changed so don't revalue before issuing the options.
yes, I've come to this second hand and am not across the whole process. I think the question is coming from the fact that it seems costly 9company pays outside provider) to have to value every 60 days. Do you have to value every 60 days regardless? The company is hiring new employees every few months so issuing options every few months and will probably raise funds once every year.
yes, I've come to this second hand and am not across the whole process. I think the question is coming from the fact that it seems costly 9company pays outside provider) to have to value every 60 days. Do you have to value every 60 days regardless? The company is hiring new employees every few months so issuing options every few months and will probably raise funds once every year.
Thanks. I was unclear on my question. If the option valuation on 1 Jan is £10 and circumstances change (e.g. capital is raised) on 1 April, is there a fine if new valuation is requested 1 Aug rather than by 1 June (within 60 days)?
Thanks. I did a bit of reading this morning and it seems like the supplier should include VAT on the invoice even if it is shipped to the USA. So on your point 1, then, I agree assuming supplier puts VAT on invoice.
Hi Les,
The business is a research study on nutrition. The main study takes place in the UK, however there will be a very small study in the US. All components such as medical devices will be shipped from supplier country of origin to the US. Medical sample results will then be shipped from US to supplier country of origin (European). All supplier invoices will be to the UK VAT registered company. The company is at research stage so has no customers or revenue. Thanks, Margaret
I'm probably ok on the rates side for now, but will be in touch if I need a good comparison. Thanks,
Thanks Leanne. I'll give them a call Monday - they get good reviews.